This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Aug 20;29(24):3340; author reply 3341-2.

doi: 10.1200/JCO.2011.36.9850. Epub 2011 Jul 18.

ZORO study: discrepancy between the conclusion and the results

Zeev Blumenfeld

PMID: 21768460
DOI: 10.1200/JCO.2011.36.9850

Comment

ZORO study: discrepancy between the conclusion and the results

Zeev Blumenfeld. J Clin Oncol. 2011.

. 2011 Aug 20;29(24):3340; author reply 3341-2.

doi: 10.1200/JCO.2011.36.9850. Epub 2011 Jul 18.

Author

Zeev Blumenfeld

PMID: 21768460
DOI: 10.1200/JCO.2011.36.9850

No abstract available

PubMed Disclaimer

Comment on

Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study.
Gerber B, von Minckwitz G, Stehle H, Reimer T, Felberbaum R, Maass N, Fischer D, Sommer HL, Conrad B, Ortmann O, Fehm T, Rezai M, Mehta K, Loibl S; German Breast Group Investigators. Gerber B, et al. J Clin Oncol. 2011 Jun 10;29(17):2334-41. doi: 10.1200/JCO.2010.32.5704. Epub 2011 May 2. J Clin Oncol. 2011. PMID: 21537042 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information